Search Results - "Fea, E"

A review on microbiological decontamination of fresh produce with nonthermal plasma by Pignata, C., D'Angelo, D., Fea, E., Gilli, G.

“…Summary Food safety is a critical public health issue for consumers and the food industry because microbiological contamination of food causes considerable…”
Get full text

Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO by Dell’Aquila, E., Cremolini, C., Zeppola, T., Lonardi, S., Bergamo, F., Masi, G., Stellato, M., Marmorino, F., Schirripa, M., Urbano, F., Ronzoni, M., Tomasello, G., Zaniboni, A., Racca, P., Buonadonna, A., Allegrini, G., Fea, E., Di Donato, S., Chiara, S., Tonini, G., Tomcikova, D., Boni, L., Falcone, A., Santini, D.

“…Neutrophil/lymphocyte ratio (NLR), defined as absolute neutrophils count divided by absolute lymphocytes count, has been reported as poor prognostic factor in…”
Get full text

Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial by Masi, G., Salvatore, L., Boni, L., Loupakis, F., Cremolini, C., Fornaro, L., Schirripa, M., Cupini, S., Barbara, C., Safina, V., Granetto, C., Fea, E., Antonuzzo, L., Boni, C., Allegrini, G., Chiara, S., Amoroso, D., Bonetti, A., Falcone, A.

“…The BEBYP trial is a prospective, randomized, open-label, multicenter, phase III study evaluating the continuation or reintroduction of bevacizumab with…”
Get full text

Correlation between values of specific biomarkers and outcome in metastatic colorectal cancer patients treated with regorafenib by Ricci, V., Falletta, A., Granetto, C., Paccagnella, M., Abbona, A., Fea, E., Fabozzi, T., Lo Nigro, C., Merlano, M.

Get full text

Analysis of environmental endocrine disrupting chemicals using the E-screen method and stir bar sorptive extraction in wastewater treatment plant effluents by Bicchi, C., Schilirò, T., Pignata, C., Fea, E., Cordero, C., Canale, F., Gilli, G.

“…Endocrine disrupting chemicals (EDCs) have become a major issue in the field of environmental science due to their ability to interfere with the endocrine…”
Get full text

The process of truth disclosure: an assessment of the results of information during the diagnostic phase in patients with cancer by Numico, G., Anfossi, M., Bertelli, G., Russi, E., Cento, G., Silvestris, N., Granetto, C., Di Costanzo, G., Occelli, M., Fea, E., Garrone, O., Gasco, M., Colantonio, I., Merlano, M.

“…Surveys carried out in Mediterranean countries demonstrated very low rates of awareness of both diagnosis and prognosis among cancer patients. In our…”
Get full text

Toxicity and estrogenic activity of a wastewater treatment plant in Northern Italy by Schiliró, T, Pignata, C, Fea, E, Gilli, G

“…Many xenobiotics, widely diffused in the environment, have the potential to disrupt the delicate endocrine system balance of wildlife and humans. Substances…”
Get full text

Application of semipermeable membrane device for assessing toxicity in drinking water by Gilli, G., Schilirò, T., Pignata, C., Traversi, D., Carraro, E., Baiocchi, C., Aigotti, R., Giacosa, D., Fea, E.

“…Semipermeable membrane devices (SPMDs) mimic passive diffusive transport of bioavailable hydrophobic organic compounds through biological membranes and their…”
Get full text

Impact of a wastewater treatment plant on Cryptosporidium oocysts and Giardia cysts occurring in a surface water by CARRARO, E, FEA, E, SAIVA, S, GILLI, G

“…The aim of this study was to assess the impact of a municipal wastewater treatment plant (MWTP) on the occurrence of Cryptosporidium oocysts and Giardia cysts…”
Get full text

Serological Evidence of Cryptosporidium Infections in Southern Europe by Frost, F. J., Fea, E., Gilli, G., Biorci, F., Muller, T. M., Craun, G. F., Calderon, R. L.

“…Although cryptosporidiosis outbreaks have been frequently reported in the United States, Canada and the United Kingdom, few outbreaks have been reported on the…”
Get full text

P-140Correlation between values of specific biomarkers and outcome in metastatic colorectal cancer patients treated with regorafenib by Ricci, V, Falletta, A, Granetto, C, Paccagnella, M, Abbona, A, Fea, E, Fabozzi, T, Lo Nigro, C, Merlano, M

Get full text

O-12 Phase II study of preoperative chemoradiotherapy plus avelumab in patients with locally advanced rectal cancer: The AVANA study by Salvatore, L., Bensi, M., Corallo, S., Bergamo, F., Pellegrini, I., Rasola, C., Borelli, B., Tamburini, E., Randon, G., Galuppo, S., Boccaccino, A., Viola, M., Auriemma, A., Fea, E., Barbara, C., Corvari, B., Bustreo, S., Smiroldo, V., Barbaro, B., Tortora, G.

Get full text

619P Maintenance versus discontinuation of androgen deprivation therapy during docetaxel administration with a continuous or an intermittent schedule in metastatic, castration resistant, prostate cancer patients: A multicenter randomized phase III study of the Piemonte Oncology Network by Berruti, A., Mosca, A., Bianchi, S., Prati, V., Ortega, C., Buttigliero, C., Fea, E., Vanella, P., Valcamonico, F., Ciccone, G., Sirotova, Z., Chiappino, I., Canton, O. Dal, Masini, C., Sacco†, C., Amoroso, D., Montagnani, F., Comandone, A., Gennari, A., Tucci, M.

Get full text

1950P TRANSLATE: Activation of immune response in refractory patients to standard treatment by Merlano, M.C., Paccagnella, M., Garrone, O., Falletta, A., Fea, E., Abbona, A., Lo Nigro, C., Gammaitoni, L., Vanella, P., Monteverde, M., Granetto, C., Occelli, M., Denaro, N., Merlotti, A., Reali, A., Sangiolo, D.

Get full text

p53 evaluation in gastric mucosa of patients with chronic Helicobacter pylori infection by Marinone, C, Martinetti, A, Mestriner, M, Seregni, E, Geuna, M, Ferrari, L, Strola, G, Bonardi, L, Fea, E, Bombardieri, E

“…Gastric cancer is often associated with p53 over-expression and Helicobacter pylori (HP) infection. In this study we have investigated the production of the…”
Get more information

578PPrognostic and predictive role of body mass index (BMI) in metastatic colorectal cancer (mCRC): A pooled analisys of TRIBE and TRIBE-2 studies by GONO by Dell’Aquila, E, Rossini, D, Stellato, M, Bergamo, F, Aprile, G, Morano, F, Intini, R, Fea, E, Ronzoni, M, Libertini, M, Buonadonna, A, Fanchini, L, Marcucci, L, Maiello, E, Marmorino, F, Boccaccino, A, Cordio, S, Masi, G, Falcone, A, Santini, D

“…Abstract Background Obesity is associated with an increased risk of development and recurrence of colorectal cancer. The role of obesity in mCRC patients (pts)…”
Get full text

Prognostic and predictive role of body mass index (BMI) in metastatic colorectal cancer (mCRC): A pooled analisys of TRIBE and TRIBE-2 studies by GONO by Dell’Aquila, E., Rossini, D., Stellato, M., Bergamo, F., Aprile, G., Morano, F., Intini, R., Fea, E., Ronzoni, M., Libertini, M., Buonadonna, A., Fanchini, L., Marcucci, L., Maiello, E., Marmorino, F., Boccaccino, A., Cordio, S., Masi, G., Falcone, A., Santini, D.

Get full text

578P - Prognostic and predictive role of body mass index (BMI) in metastatic colorectal cancer (mCRC): A pooled analisys of TRIBE and TRIBE-2 studies by GONO by Dell’Aquila, E., Rossini, D., Stellato, M., Bergamo, F., Aprile, G., Morano, F., Intini, R., Fea, E., Ronzoni, M., Libertini, M., Buonadonna, A., Fanchini, L., Marcucci, L., Maiello, E., Marmorino, F., Boccaccino, A., Cordio, S., Masi, G., Falcone, A., Santini, D.

“…Obesity is associated with an increased risk of development and recurrence of colorectal cancer. The role of obesity in mCRC patients (pts) is still unclear,…”
Get full text

Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion by Numico, Gianmauro, Cristofano, Antonella, Occelli, Marcella, Sicuro, Marco, Mozzicafreddo, Alessandro, Fea, Elena, Colantonio, Ida, Merlano, Marco, Piovano, Pierluigi, Silvestris, Nicola

“…Malignant pericardial effusion (MPE) is a serious complication of several cancers. The most commonly involved solid tumors are lung and breast cancer. MPE can…”
Get full text

P160 MEMORIAE: A multicenter prospective study evaluating cognitive functioning in patients (pts) with metastatic Castration ResIstant Prostate Cancer (mCRPC) treated with ABIraterone (ABI) or ENZAlutamide (ENZA) by Turco, F., Filippi, R., Numico, G., Pisano, C., Fea, E., Vanella, P., Vignani, F., Prati, V., Rossi, M., Guglielmini, P., Palesandro, E., Di Stefano, F.R., Saporita, I., Calabrese, M., Bovero, A., Di Maio, M., Ortega, C., Tucci, M., Buttigliero, C.

Get full text